Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You’ve already made millionaires of several of your “friends.”
I’ve been told that middle finger emojis are the most highly compensated.
Everyone would be better off having a baseline comparison. Obviously every biotech and their stocks have different characteristics of one form or another. But it’s helpful to at least have something to compare against.
If the bulls on this message board are concerned about the inference, then think about this homework assignment as preparing investors for their next biotech investments when NWBO is acquired.
As a board monitor, the authority vested in me bestows the right to hand out a homework assignment.
Assignment: Everyone should buy some very modest amount of stock in another small cap biotech that’s traded on Nasdaq that has had some measure of success (however you want to define)…the biotech should have a drug pipeline anywhere between late stage III and early commercial stage. Then compare that biotech company and its stock to that of NWBO.
Grade: Pass/Fail.
P.S. Yesterday’s CrowdStrike screwup made me feel like I was working in the Stone Age.
There is still enormous risk. This is an OTC traded stock that is funded by ongoing and substantial dilution of its stock price.
All their eggs are in one basket with MHRA. And who knows how long the approval will take? And we assume approval, but that’s not 100% certain either.
I’m not a believer that the MTD will be denied. And nobody should be investing in this stock because of how they believe a judge will rule on this motion. The fact that so much attention is devoted to this one non-core issue is telling.
A lot of potential upside, but that goes along with the big downside risk.
That’s right. This is an enormously risky stock, and different opinions should be considered without attacking the messengers.
The stock is trading at multi year lows, so all longs have taken big hits on the value of their NWBO stock. Some of us could and still can afford to take the risk with holding this stock, but others don’t have that luxury and should understand and carefully consider both bull and bear arguments.
That was actually said by Les to me in response to a question I posed to LP at that ASM. The refreshment table was much smaller that year. Certainly no cannoli tray.
I believe it was circa 2016 or 2017 after the stock price had dropped from a high of $10 earlier in the year to 37 cents. Hard to believe after all this time, the price is trading in the same range; almost surreal. Also worth noting, they were well into the phase III trials at that time — the question was hardly outside the norm.
I’m a gutsy guy.
You listen to too much propaganda.
The vote count was somewhat higher than I expected, which wasn’t actually announced at the ASM.
So no, I still enjoyed the refreshments. Stuck a cannoli in my pocked as I left, since I had already paid for it many times over.
LP should go into the catering business. Seriously though.
Questions had to be submitted in advance.
I was actually about to ask about funding efforts and listing the stock, but they weren’t taking any questions from the flock in attendance. Plus all the baaing made it hard to hear.
I really enjoyed the refreshment table. And the best cannolis I’ve had this side of Florence. I’m dying if I’m lying.
But was a little disappointed that the grass table was empty, since all the sheep arrived early.
Thank you for reminding me about Project Orbis! OMG, LOL!!!
ARQT is very new to me, so I didn’t even care to research the time from DL to approval — ancient history. But they submitted a NDA for a new indication in November, which was approve today. Not bad, and within a day or two of its PDUFA deadline.
https://www.arcutis.com/about/strategic-collaborators/
For me it was refreshing to research and own a small cap biotech that seems to have its act together. Now that I have a significant position, I’m sure it will now implode!
So my three financial advisors had this to offer —
You’re right.
I owe my wife a new set of clubs.
The only news that will be accretive this Summer (within reason) is some form of partnership that brings in a meaningful upfront payment. Not sure anything else will have much of significant lasting effect on the stock price. And I believe even restarting existing trials after a certain period of time requires RA approvals.
I actually took the bet of a quiet Summer and sold about a third of my shares. And then placed limit buy orders at a much lower price. I still retain the other two-thirds of my shares, so I still benefit from a rapid increase in the share price. Obviously this all hinges on MHRA approval in the Fall.
I also used some of the sale proceeds to buy Arcutis Bioparm last week (Steve Cohen is a large investor), and today they just received approval for a new indication. Nice feeling to finally have a success!
Flip, if there was ever a more appropriate song for this company. Really their theme song, as it were.
The sun'll come out
Tomorrow
Bet your bottom dollar
That tomorrow there'll be sun
Just thinkin' about
Tomorrow
Clears away the cobwebs
And the sorrow 'til there's none
When I'm stuck with a day
That's gray and lonely
I just stick out my chin
And grin and say, oh
The sun'll come out
Tomorrow
So ya gotta hang on
'Til tomorrow come what may
Tomorrow, tomorrow
I love ya tomorrow
You're always, a day away
The sun'll come out
Tomorrow
So ya gotta hang on
'Til tomorrow come what may
Tomorrow, tomorrow
I love ya tomorrow
You're always, a day away
Tomorrow, tomorrow
I love ya tomorrow
You're always, a day away
I like Dr. High, he’s a smart dude with a sense of humor.
I really don’t care what side of the fence a poster sits and frankly what their perceived motive might actually be (obviously within reason).
It’s a message board after all. So as long as someone is respectful, I don’t see any reason for the vitriol.
Exactly, so why would the defendants sign a joint defense agreement if they couldn’t control the information that’s shared between the parties. And that could include exculpatory evidence as well.
I’m sure the defense agreements can be structured in such a way as to restrict or ring fence what information can be shared in a settlement. But was just interested to hear your thoughts,
Viking, that’s the wisest post from you I can ever recall. I like chatting with you for the most part.
Right, we’re just sharing opinions. It’s not a death match.
Interesting, thanks.
But then how do you keep one defendant from sharing privileged information about another defendant in the case?
Thanks Hoffy!
We’ll see in a few weeks what the magistrate comes back with in her R&R. Although I’m sticking to my guns. In any event, it’s more of an academic exercise at this stage given resolution of the case could still be a year or more out even if the MTD is denied.
Interesting case though.
And one question QL: Do you think that the MMs have signed a joint defense agreement that would preclude separate settlements?
Hank, we’ll see what happens, but it’s difficult to see how Posner will clear the bar after struggling already in two similar cases. I once thought that they would at least get past the MTD stage, but after reading the response from dependents’ counsel, I really have my doubts.
Losing a MTD is not a great sign. But the judge is giving the plaintiff another opportunity to bolster their case.
Which of course begs the question: why hasn’t she presented a strong enough case from the beginning? Two cases in a row.
It was dismissed by the judge,
A motion for leave to amend I guess keeps the case barely alive, but it’s a long shot after the dismissal.
I would consider a dismissal by a judge pretty much losing the case. But sure, you can hang your hopes on a thread.
But not a good sign, is it?
It’s actually cited in one of my earlier posts. And it’s lifted directly from the last response from defendants’ counsel. Apparently you didn’t read it, but let me find the post and then you can go read it for yourself on Pacer.
I’m actually at the beach, so I don’t have all my “stuff” with me. And like any good NWBO shareholder, I also have my head buried deeply in the sand. So that makes posting a little difficult.
Oh, I found it!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174625607
Just keep in mind some of those are covered shorts. And a 5 percent short position is probably well below average. It’s too low to really believe there’s a problem.
Hedge funds lose money and fold sometimes. Maybe this stock will result in that happening at some point?
Nobody has shown any substantial short numbers. The percentages are actually relatively low as I recall.
The narrative has always been that MMs on behalf of BP short and (more recently) spoof the stock price to drive the company out of business. NWBO is certainly never going out of business with a plus $500 million market cap.
Now if somebody is swing trading, then your point is well taken. You want volatility to trade high and low. But that’s not been the narrative. And to the point about algos, those are always seeking to exploit market in- balance, but that is true with all stocks.
Because NWBO is traded with low volume, it would be relatively easy to drive the stock price down further. I actually believe in some way this dovetails into the company’s counsel having problems proving loss causation.
Not unusual for large foreign corporates to list in their home country/region. Duel listings are expensive and burdensome to manage with two sets of regulations. The US has also become very expensive in terms of reg compliance (thanks to that company that started with an “E,” and whose name shall not be spoken.)
Listing on the OTC provides easier access to US shareholders, while minimizing the cost that would otherwise be incurred from duel listings.
Posner just lost a very similar case. Hope it wasn’t on contingency and have to explain herself to the managing partner.
Crash: is Posner on 100% contingency?
Crash, I seriously doubt the MTD will survive.
You’re a broker, you know all stocks are manipulated in some form; but typically aren’t impacted over long periods in the way you guys keep asserting about NWBO.
Hate to say it, but the derivative lawsuit is not over. Hold onto your horsey when discovery begins in October.
Yes, and those are all listed on other major exchanges.
Just a random thought when I was looking at another biotech stock I own (Nasdaq: ARQT) for why it’s highly unlikely NWBO is being attacked by market makers: it’s the stock’s high market cap.
Any OTC biotech stock with a marker cap over $500 million is actually very impressive, and rarely does the market cap for an OTC get into the $ billion range (except those duel listed on a major exchange elsewhere). If market makers were in some form of conspiracy with BP to drive NWBO out of business, the market cap would be far lower and the share price would be well below 10 cents.
Congrats to the Toucan Limited Partners; good job guys, what can I say…that’s the way the game is played when you’re herding sheep.
I don’t believe anyone would doubt that approval equals cash. But approval remains well off into late 3rd quarter (which began today) or even into the 4th quarter. So the $64,000 question is where does that non-dilutive funding come from in between now and then? If not, we will get seriously diluted over the next several months.
I’m convinced there is going to a large influx of cash shortly after approval.
My big take away, it’s very obvious they need a change-over in management.
The big problem with the presentation at the ASM was there was no reason or rationale to suggest the stock price would increase over the next several months. Yes, longer term there is a value proposition, but it was impossible to make a near term argument.
What ever happened to approval in March? Was there a calendar recall that I missed because the months were placed out of order by the printer?
Nice tie by the way.
Horse, I was thinking about you today while munching on a cannoli at the ASM. I was actually going to take the serving plate full at the end, but didn’t know where to drop the gun.
The MTD is likely to be granted.
As I said Hoffy, not that you have any friends in the legal profession, but if you do, want to make sure I avoid a Missouri licensed lawyer with a conflict.
The cases is already drafted, just has to reflect Missouri statutes rather than Va.